Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Zacks Investment Research

19 Jun 2026, 16:41 UTC · 2h ago

FUL or NVZMY: Which Is the Better Value Stock Right Now?

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims

3 claims · each scored for market impact

What matters in this story

1
H. B. Fuller (FUL) currently has a Zacks Rank of #2 (Buy) and a Value grade of B. — A high analyst rank combined with a strong value grade typically suggests an undervalued stock with positive earnings momentum.
+0.30
2
Novozymes A/S (NVZMY) currently has a Zacks Rank of #3 (Hold) and a Value grade of D. — A 'Hold' rank and a low value grade suggest the stock is either fairly valued or overvalued relative to its growth prospects.
-0.20
3
H. B. Fuller's forward P/E ratio is 13.57 and PEG ratio is 0.85, compared to Novozymes A/S's forward P/E of 24.55 and PEG of 1.11. — Lower P/E and PEG ratios indicate FUL is significantly cheaper than NVZMY relative to its earnings and growth.
+0.20